Helen Hughes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Helen Hughes has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- John F. Gamble
Drug Product Development, Bristol Myers Squibb, Reeds Lane, Moreton, CH46 1QW, UK
2 shared publications - Mike Tobyn
Bristol-Myers Squibb
2 shared publications - Andrew Parker
Molecular Profiles, Nottingham Business Park, Nottingham, NG8 6PX, UK
1 shared publication - Clive J. Roberts
School of Pharmacy
1 shared publication George Crull
Drug Product Science and Technology, Bristol-Myers Squibb, New Brunswick, New Jersey 08903-0191, USA
1 shared publicationJonathan Brown
Drug Product Science and Technology, Bristol-Myers Squibb Reeds Lane, Moreton, Wirral, CH46 1QW, UK
1 shared publication
Latest Publications
- 10 October 2023
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 24 (7) , 1-6
Non-contact Laser Interferometer Method to Characterize Tablet Punches: New Methodology to Assess Surface Roughness
Sticking to tablet punches is a major issue during drug product manufacturing. Research has shown that sticking involves the interrelationship of powder pr
- 10 October 2023
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 24 (7) , 1-6
Non-contact Laser Interferometer Method to Characterize Tablet Punches: New Methodology to Assess Surface Roughness
Sticking to tablet punches is a major issue during drug product manufacturing. Research has shown that sticking involves the interrelationship of powder pr
- 19 September 2014
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 16 (1) , 165-170
Development of a Material Sparing Bulk Density Test Comparable to a Standard USP Method for Use in Early Development of API’s
Bulk density can be a key indicator of performance, and may influence choice of formulation route of materials in pharmaceutical development. During early development, the cost of API’s can be expensive and the availability of material for powder property analysis is limited. The aim of this work was to investigate a suitable small-scale, low material requirement, bulk density test which would provide comparable data to the recommended large volume USP test. Materials with a range of morphological characteristics typically seen in the pharmaceutical industry were assessed to ensure that methods were suitably robust. It was found that the USP II “low volume” test does not give equivalent results to other tests in the USP, across the range of materials. An alternative test based on the FT4 powder rheometer at a scale of 25 mL gave results equivalent to the large volume USP I standard test. The use of smaller 10-mL methods was also found to give acceptable results for materials that were considered well-behaved but were more variable with difficult to handle materials with low bulk density.
- 19 September 2014
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 16 (1) , 165-170
Development of a Material Sparing Bulk Density Test Comparable to a Standard USP Method for Use in Early Development of API’s
Bulk density can be a key indicator of performance, and may influence choice of formulation route of materials in pharmaceutical development. During early development, the cost of API’s can be expensive and the availability of material for powder property analysis is limited. The aim of this work was to investigate a suitable small-scale, low material requirement, bulk density test which would provide comparable data to the recommended large volume USP test. Materials with a range of morphological characteristics typically seen in the pharmaceutical industry were assessed to ensure that methods were suitably robust. It was found that the USP II “low volume” test does not give equivalent results to other tests in the USP, across the range of materials. An alternative test based on the FT4 powder rheometer at a scale of 25 mL gave results equivalent to the large volume USP I standard test. The use of smaller 10-mL methods was also found to give acceptable results for materials that were considered well-behaved but were more variable with difficult to handle materials with low bulk density.
- 1 December 2013
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 102 (12) , 4375-4383
Imaging Dehydration Kinetics of a Channel Hydrate Form of the HIV-1 Attachment Inhibitor Prodrug BMS-663068
- 1 December 2013
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 102 (12) , 4375-4383
Imaging Dehydration Kinetics of a Channel Hydrate Form of the HIV-1 Attachment Inhibitor Prodrug BMS-663068